First line combination chemotherapy with cisplatin and etoposide in advanced ovarian cancer. (Record no. 2809816)

MARC details
000 -LEADER
fixed length control field 01292 a2200385 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250512020956.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 198912s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0007-0920
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1038/bjc.1989.353
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Athanassiou, A E
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19891215
245 00 - TITLE STATEMENT
Title First line combination chemotherapy with cisplatin and etoposide in advanced ovarian cancer.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. British journal of cancer
Date of publication, distribution, etc. Nov 1989
300 ## - PHYSICAL DESCRIPTION
Extent 755-8 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cisplatin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Evaluation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Etoposide
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ovarian Neoplasms
General subdivision drug therapy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bafaloukos, D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pectasides, D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dimitriadis, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Varthalitis, I
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Barbounis, V
773 0# - HOST ITEM ENTRY
Title British journal of cancer
Related parts vol. 60
-- no. 5
-- p. 755-8
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1038/bjc.1989.353">https://doi.org/10.1038/bjc.1989.353</a>
Public note Available from publisher's website

No items available.